Cell Biology & Biotechnology
Contact UsApply for AdmissionCourses & RegistrationLibrary
Cell Biology & Biotenchnology Gradient

Pharmaceutical Business Course Descriptions

Managerial and Financial Accounting, PB711

This course provides the participant with an understanding of accounting terminology, how to read and analyze financial statements, how to develop product costs, and how to analyze and measure performance in the plant, with an emphasis on how to use some of the measurements outside of the manufacturing environment. Also, activity-based costing concepts are examined and applied in exercises, in addition to applying cost/volume profit analysis to marketing situations.

(Back to top)

Managerial and Financial Accounting, PB712

This course provides the participant with an understanding of accounting terminology, how to read and analyze financial statements, how to develop product costs, and how to analyze and measure performance in the plant, with an emphasis on how to use some of the measurements outside of the manufacturing environment. Also, activity-based costing concepts are examined and applied in exercises, in addition to applying cost/volume profit analysis to marketing situations.

(Back to top)

Managerial Finance, PB721

This course covers the basics concepts of finance, including the ability to read key business statements such as balance sheets, income statements, and sources and uses statements. The course discusses the main forms of business organization and the finance function itself. The course continues with an overview of financial markets and institutions, as well as a description of the various major types of debt and equity. Students will learn fundamental financial concepts such as present value and future values, risk-and-return principles, and financial portfolio analysis. The course will pay particular attention to understanding the issues involved in long-term investment decisions, which are so critical to the pharmaceutical industry.

(Back to top)

Corporate Finance, PB722

This course covers concepts such as valuation principles, including the time value of money, interest rates, diversification, risk and return, debt, and equity, as well as the options. Investments and financial operations will also be addressed. The course will also examine the major questions of financial policy and planning, including long-term dividends and capital structure, investment analysis, restructuring, and long-term financial planning.
(Prerequisite: PB721)

(Back to top)

Mergers and Acquisitions, PB723

The course presents the key financial and managerial issues involved in the merger and acquisition process. It covers the business reasons for making an acquisition or merger or deciding to sell a business or business unit. The course addresses evaluating and valuing a potential acquisition, forms and characteristics of mergers, and the financial alternatives involved in mergers or acquisitions. Particular attention is devoted to identifying the characteristics of successful mergers in general and in the pharmaceutical industry, in particular.
(Prerequisite: PB721)

(Back to top)

Financial Management and Governance, PB725

This course covers the basics concepts of finance, including the ability to read key business statements such as balance sheets, income statements, and sources and uses statements. The course discusses the main forms of business organization and the finance function itself. The course continues with an overview of financial markets and institutions, as well as a description of the various major types of debt and equity. Students will learn fundamental financial concepts such as present value and future values, risk-and-return principles, and financial portfolio analysis. The course will pay particular attention to understanding the issues involved in long-term investment decisions, which are so critical to the pharmaceutical industry.
(Prerequisite: PB712 and PB733)

(Back to top)

Capital Investment and Financing, PB726

This course covers concepts such as valuation principles, including the time value of money, interest rates, diversification, risk and return, debt, and equity, as well as the options. Investments and financial operations will also be addressed. The course will also examine the major questions of financial policy and planning, including long-term dividends and capital structure, investment analysis, restructuring, and long-term financial planning.
(Prerequisite: PB725)

(Back to top)

Business Statistics, PB731

This course provides the student with an understanding of the common statistical methods used in business analysis for marketing, operations, and R&D. It examines probability, sampling methods, measurement scales, measures of central tendency, dispersion, association statistical process control, and statistical quality control, as well as univariate and multivariate distributions of data structures. The course also introduces various statistical software packages, such as SPSS and SAS.

(Back to top)

Pharmacoeconomics and Economics of Health Care, PB732

This course equips the student with an understanding of the pharmacoeconomics of specific drugs as well as macroeconomic and microeconomic concepts, how to read and analyze economic and pharmacoeconomic reports, how to develop clinical economic studies, and how to analyze and measure inputs and outcomes. Tools covered include cost-benefit, cost-effectiveness, and cost-utility analysis. In addition, the course covers how to apply economic analysis to marketing situations.
(Prerequisite: PB751)

(Back to top)

Business Statistics, PB733

This course provides the student with an understanding of common statistical methods used in business analysis for marketing, operations, and R&D. The course examines probability, sampling methods, measurement scales, measures of central tendency, dispersion, association statistical process control, and statistical quality control, as well as univariate and multivariate distributions of data structures. The course also introduces various statistical software packages, such as SPSS and SAS.

(Back to top)

Team Dynamics-Human Resources, PB741

Organizations are rapidly adapting to change, with significant implications for leadership and organization. Teams are becoming increasingly important, and leaders find they must be able to operate in a virtual environment. The course covers the essentials of successful human resources management illustrated through exercises in team dynamics. This course also covers the nature and practice of effective leadership in a team-based environment. The course has the goal of enhancing the teamwork skills of each participant as well as providing a firm grasp of the dynamics.

(Back to top)

Leadership and Development, PB742

The course identifies the characteristics of successful leaders and managers in modern corporations. In addition, it examines the components of a successful organization, exploring organizational integration, environment, structure, performance, and administration. The course then focuses on polishing students' leadership and organizational management skills.

(Back to top)

Leadership, Team Dynamics, and Human Resources Management, PB743

Organizations are rapidly adapting to change, with significant implications for leadership and organization. Teams are becoming increasingly important, and leaders find they must be able to operate in a virtual environment. This course focuses on the nature and practice of effective leadership in a team-based environment. Course format is highly experimental with the goal of enhancing the leadership and teamwork skills of each participant.

(Back to top)

Introduction to Marketing, PB751

The course is designed to introduce the student to the basic concepts in marketing so students understand the similarities between pharmaceutical marketing and other industries in addition to the distinctive areas of pharmaceutical marketing. The course covers analyzing market opportunities, planning marketing programs, formulating product strategy, structuring the market mix, and managing the marketing program.

(Back to top)

Introduction to Market Research, PB752

This course examines qualitative methods, such as focus groups and individual in-depth interviews, and quantitative methods, such as self-administered questionnaires, conjoint analysis, discrete choice models, Internet surveys, and various hybrid marketing research methods. Application of results in designing and testing marketing communications, SWOT analysis, and designing and evaluating marketing tactics will be explored.
(Prerequisites: PB751 and PB731)

(Back to top)

Pharmaceutical Marketing and Sales Management, PB753

The course covers the distinctive features of the American health care market, including formulary decision making, managed care and third-party insurance providers, retail outlets, direct-to-consumer marketing, and government reimbursement issues. The tactical portion of the course is divided into three segments: (1) pharmaceutical marketing, (2) strategy and implementation, and (3) development of a comprehensive cross-functional tactical and promotional plan. Students will use teamwork to develop and present their plan.
(Prerequisite: PB751)

(Back to top)

Brand Management, PB754

The course focuses on branding concepts and techniques appropriate for product managers and marketers. It covers research and planning approaches through a wide range of brand strategies, including market segmentation, product line marketing, physical services, and the use of public relations and advertising. Additional topics include branding approaches for building patient loyalty and strategies for dealing with the diverse institution's product mix. The course will also include contemporary case studies illustrating branding decisions faced by health care professionals.
(Prerequisite: PB755)

(Back to top)

Introduction to Marketing, PB755

The course is designed to introduce the student to the basic concepts in marketing so students understand the similarities between pharmaceutical marketing and other industries in addition to the distinctive areas of pharmaceutical marketing. The course covers analyzing market opportunities, planning marketing programs, formulating product strategy, structuring the market mix, and managing the marketing program.

(Back to top)

Pharmaceutical Marketing and Sales Management, PB756

The course covers the distinctive features of the American health care market, including formulary decision making, managed care and third-party insurance providers, retail outlets, direct-to-consumer marketing, and government reimbursement issues. The tactical portion of the course is divided into three segments: (1) pharmaceutical marketing, (2) strategy and implementation, and (3) development of a comprehensive cross-functional tactical and promotional plan. Students will work in teams to develop and present their own plan.
(Prerequisite: PB755)

(Back to top)

Introduction to Market Research, PB757

This course examines qualitative methods, such as focus groups and individual in-depth interviews, and quantitative methods, such as self-administered questionnaires, conjoint analysis, discrete choice models, Internet surveys, and various hybrid marketing research methods. Application of results in designing and testing marketing communications, SWOT analysis, and designing and evaluating marketing tactics will be explored.
(Prerequisites: PB751 and PB731)

(Back to top)

Competitive Analysis and Strategic Business Planning, PB761

This course provides an in-depth understanding of the process of competitive analysis and business planning in the pharmaceutical industry. Focus will be on how to analyze the competition's strengths and weaknesses, product life-cycle analysis, and therapeutic portfolio management.
(Prerequisites: PB721 and PB751)

(Back to top)

Pharmaceutical Research and Development Management, PB762

The course reviews, in depth, the elements of managing the research and development process in pharmaceutical companies. It includes an introduction to the major R&D components of drug discovery, preclinical development, clinical development, project management, and pharmaceutics. The course will take students through a case study of a drug development program.

(Back to top)

New Product Development, PB763

This course provides an overview of portfolio analysis, the drug development process, and the factors necessary for economic success in the marketplace. Particular attention will be devoted to the role of marketing in the R&D process.
(Prerequisite: PB762)

(Back to top)

Pharmaceutical R&D and New Product Development, PB764

The course reviews the elements of managing the research-and-development process in a pharmaceutical company. It includes an introduction to the major R&D components of drug discovery, preclinical development, clinical development, project management, and pharmaceutics. The course will take students through a case study of a drug development program.

(Back to top)

Business Strategy, PB765

This course provides an in-depth understanding of the process of competitive analysis and strategic planning in the pharmaceutical industry. It includes an overview of major schools of strategic thought and how these schools have influenced strategy in the pharmaceutical industry. Students work in teams with a senior executive from a pharmaceutical company to solve a strategic issue. Final and mid-term presentations are made to faculty and a pharmaceutical executive.
(Prerequisite: PB755)

(Back to top)

Regulation of Prescription Drugs and Ethical Issues, PB771

Drug regulation spans the entire scope of the pharmaceutical business. The course addresses the role of regulatory agencies in manufacturing, marketing, and marketing support material. In addition, the course examines the role of regulatory agencies outside the United States in their own markets. In-depth attention is devoted to regulatory agencies in new product development and product safety overview. The course also covers the major ethical issues in the delivery of general health care and pharmaceutical health care from the perspective of public policy and the pharmaceutical industry.

(Back to top)

Introduction to Health Policy, PB772

The course provides students with knowledge of the basic structures of the American health care system in terms of its key components and their interrelations and refines students' abilities to identify health policy issues in terms of conflicts and common themes. The course also touches on the basic health care structures of Europe and Japan, highlighting similarities and differences with the American system.

(Back to top)

Regulation of Prescription Drugs, PB773

Drug regulation spans the entire scope of the pharmaceutical business. The course addresses the role of regulatory agencies in marketing and marketing support material. In addition, the course examines the role of regulatory agencies outside the United States. Regulation of product manufacturing is also discussed. In-depth attention is devoted to regulatory agencies in new product development and product safety overview.

(Back to top)

Ethical Issues in Pharmaceutical Business, PB774

This course addresses the role of ethics in the U.S. pharmaceutical industry, along with a brief discussion of ethical standards in the pharmaceutical markets of Europe, Asia, and other regions. Marketing, clinical trials, compliance, sales, and other pharmaceutical-related issues will be examined from an ethical perspective. In addition to specific ethical issues in the drug industry, general business ethics and medical ethics will also be briefly covered.

(Back to top)

Business Communications and Information Strategies, PB780

This course provides new graduate students in the online MBA program with an introduction to: oral, written, and virtual communication; methods for finding and evaluating course resources; online research techniques; critical thinking, the purpose and benefits of the MSM (Multidiscipline Strategic Management) project, program standards; stress and time management; and learning team process. The design of the course will also assist students in mastering the online learning environment and developing collegial relationships with their cohort members.

(Back to top)

Multidiscipline Strategic Management I and II, PB791 and PB792

MSM is a two-part course that runs throughout the entire program, from the initial week to the final (capstone course). Students working in teams are asked to construct a hypothetical pharmaceutical company that, in principle, could compete in today's marketplace. The purpose of this course is to integrate what students have learned in all of the MBA program's individual classes. Students construct their hypothetical company, including a full description of the health care and competitive environments, company product(s), and company organizational design, along with related management, personnel, financing, and strategic issues. Students will also develop a case study, detailing one or more major strategic issues their company might face and how their company might successfully address these issues. Students defend their case study to a panel of professors. The hypothetical company will also be used in the final, and separate, capstone course.

(Back to top)

Multidiscipline Strategic Management I, PB795

This course provides students with an overall understanding of how a pharmaceutical company operates, including both the internal structure and the company's interaction with its external environment, as well as the issues and problems that might affect or impact the company and how it might address those issues. The course is not lecture-based but is instead a student-centered-learning course. Students will work as teams in order to develop a full profile of a hypothetical pharmaceutical company. The teams must describe all aspects of how their hypothetical company does business. The course requires the students to utilize the information they are gaining in their other MBA courses, tie all this information together so that they understand how it all interrelates, and use this knowledge as a foundation to create a profile of this hypothetical pharmaceutical company. Student teams will present and defend their company profile to faculty at the end of the semester.

(Back to top)

Multidiscipline Strategic Management II, PB796

Building on the work done in the MSM I course, MSM II provides students with a deeper understanding of how a pharmaceutical company operates, as well as covering the issues and problems that might affect or impact the company and how it might address those issues. The course is not lecture-based but is instead a student-centeredlearning course. Students will continue to develop their case study of a hypothetical pharmaceutical company by developing a global strategic response to a challenge faced by the company. At the end of the semester the teams will present their findings and defend and discuss them with the faculty advisors. Guest lecturers, mentors, and written exercises will be part of the educational experience.
(Prerequisite: PB795)

(Back to top)

Multidiscipline Strategic Management III, PB797

MSM III is the third part of a three-semester series of courses where the students get a broad, in-depth understanding of the kinds of issues that corporations must deal with in the pharmaceutical industry. The course is not lecture- based but is instead a student-centered-learning course. In MSM III, the students use the knowledge gained in MSM I and II to interact with representatives of an actual pharmaceutical company. The goal is to understand how pharmaceutical companies solve real issues by actually participating in the problem analysis and problem solving process.
(Prerequisite: PB795 and PB796)

(Back to top)

International Pharmaceutical Business, PB880

This course provides an overview of global markets in the pharmaceutical industry. Global competitiveness based on the effects of national regulatory environments and economic and market factors will be explored. Issues such as the drug approval process, pricing decisions, and intellectual property will be discussed.
(Prerequisites: PB751 and PB791)

(Back to top)

Capstone: Global Business Strategies, PB890

This course summarizes and expands on the learning from the entire program based on the hypothetical pharmaceutical company developed in MSM I and II. The course incorporates active decision making, use of marketing plans and strategy development, and implementation. A computer simulation may be used as part of this course.

(Back to top)

Health Economics, PA840

This course focuses on the development and assessment of economic tools for pharmaceutical interventions and health services. It covers determining patient preferences and quality of life.
(Prerequisite: PB733)

(Back to top)

Issues and Trends in Health Policy, HP707

This course provides an orientation to analytical and substantive components that are necessary for understanding current health policy issues. Students gain an awareness of the complexities of major issues, such as the uninsured, quality assessment and disparities in outcomes, their historical evolution, and the nature of how different interests and actors interact in shaping them. They also learn to apply commonly used frameworks for policy analysis to a range of current health policy issues and themes.

(Back to top)

Risk Assessment, Critical Thinking and Health, HP725

The basics of risk assessment as an analytical tool and its application to aid decision making on health issues will be discussed. Examples will be drawn from uses of risk assessment by health and environment regulatory agencies, including the EPA, the FDA, the CDC, and others. Alternative techniques of risk assessment will be presented. Examples from the literature and popular press will be used to illustrate the application of critical thinking in the development of appropriate risk models.

(Back to top)

Health Services and Policy, HP808

This course analyzes the economic and organizational foundations of health care, including issues related to the past, present and future of the health system and health care professions. The social and economic factors affecting health policy will be studied, as well as the role of health practitioners relative to health institutions, governmental agencies and patients.

(Back to top)